Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01429389 · ClinicalTrials.gov registry record
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
A clinical trial of Down Syndrome and Fetal Aneuploidy, sponsored by Sequenom.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 14
- Study locations
NCT01429389: Recruiting study of Down Syndrome and Fetal Aneuploidy, sponsored by Sequenom.
NCT01429389 is a study of Down Syndrome and Fetal Aneuploidy that is actively recruiting participants, run by Sequenom. The registered enrollment target is 2,000 participants, below the 2,435-participant average among 54 other Down Syndrome trials with a reported enrollment target (18% lower). The trial reports 14 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01429389, a study of Down Syndrome and Fetal Aneuploidy, is actively recruiting participants, sponsored by Sequenom.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Conditions Studied
Study Locations (14)
California
- Cedars-Sinai Medical Center - Los Angeles
- Sharp-Rees Stealy Medical Group - San Diego
- UCSD - San Diego
- Women's Health Care Research - San Diego
- Specialty Obstetrics of San Diego - San Diego
Michigan
- Henry Ford Hospital - Detroit
- Spectrum Health - Grand Rapids
Alabama
- University of Alabama Birmingham - Birmingham
Illinois
- Reproductive Genetics Institute - Chicago
Iowa
- University of Iowa Health Care - Iowa City
New Jersey
- The Cooper Health System - Camden
South Carolina
- Medical University of South Carolina - Charleston
Nova Scotia
- IWK Health Centre - Halifax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2011-05 |
| Est. Completion | 2026-03 |
What NCT01429389 shows while recruiting
NCT01429389 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 2,435-participant average among 54 other Down Syndrome trials with a reported enrollment target (18% lower).
The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01429389 lists 14 locations in 9 states (California, Michigan, Alabama).
Frequently Asked Questions
What is clinical trial NCT01429389 about?
NCT01429389 is a clinical study titled "Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy". The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
What is the current status of trial NCT01429389?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2011-05. Estimated completion is 2026-03.
What conditions does trial NCT01429389 study?
This clinical trial studies the following conditions: Down Syndrome, Fetal Aneuploidy.
Who is sponsoring clinical trial NCT01429389?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01429389 being conducted?
This trial has 14 study locations across Alabama, California, Illinois, Iowa, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Down Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01429389's enrollment target sits among peer trials
2,000 7th of 54 higher than 48 of 54 other Down Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Down Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RECRUITING
-
The Human Trisome Project
RECRUITING
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia